| |
| |
|
| Insider
Information: |
Shemesh Shay |
| Relationship: |
Chief Dev. & Ops. Offi... |
| City: |
Fort Lee |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,491,955 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,491,955 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvectis Pharma, Inc. |
NVCT |
Chief Dev. & Ops. Offi... |
2024-01-03 |
1,491,955 |
2022-02-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
130,000 |
1,491,955 |
0 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2023-03-21 |
4 |
B |
$11.99 |
$5,036 |
D/D |
420 |
1,361,955 |
2.74 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2023-03-15 |
4 |
B |
$10.71 |
$7,176 |
D/D |
670 |
1,361,535 |
2.74 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2023-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
1,360,865 |
0 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-12-21 |
4 |
B |
$7.65 |
$3,825 |
D/D |
500 |
1,245,865 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-11-17 |
4 |
B |
$7.20 |
$1,080 |
D/D |
150 |
1,245,365 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-11-16 |
4 |
B |
$7.10 |
$1,065 |
D/D |
150 |
1,245,215 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-09-23 |
4 |
B |
$7.87 |
$1,731 |
D/D |
220 |
1,245,065 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-09-02 |
4 |
B |
$8.31 |
$3,357 |
D/D |
404 |
1,244,845 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-09-01 |
4 |
B |
$8.07 |
$12,347 |
D/D |
1,530 |
1,244,441 |
2.74 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-08-31 |
4 |
B |
$8.07 |
$11,911 |
D/D |
1,476 |
1,242,911 |
2.74 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-05-20 |
4 |
B |
$16.54 |
$4,962 |
D/D |
300 |
1,241,435 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-05-17 |
4 |
B |
$19.55 |
$2,776 |
D/D |
142 |
1,241,135 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-05-16 |
4 |
B |
$19.28 |
$1,928 |
D/D |
100 |
1,240,993 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-05-12 |
4 |
B |
$14.58 |
$20,255 |
D/D |
1,278 |
1,240,893 |
2.74 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Dev. & Ops. Officer |
• – – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
1,239,615 |
0 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Development OfficerOffic |
• – – |
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,176,669 |
|
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Development Officer |
• – – |
2022-02-07 |
4 |
B |
$3.47 |
$2,936 |
D/D |
846 |
1,179,615 |
2.66 |
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Chief Development Officer |
• – – |
2022-02-04 |
4 |
B |
$3.38 |
$7,098 |
D/D |
2,100 |
1,178,769 |
2.74 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
